Brenner Tumor - 10 Studies Found Estado Estudiar Completed Nombre del estudio: Belinostat and Carboplatin in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Carboplatin or Cisplatin Condición: Brenner Tumor Fallopian Tube Cancer Drug: belinostat Given IV Completed Nombre del estudio: Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous Chemotherapy Condición: Brenner Tumor Fallopian Tube Cancer Biological: sargramostim Given Completed Nombre del estudio: Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer) Condición: Brenner Tumor Fallopian Tube Cancer Drug: carboplatin Given intrap Completed Nombre del estudio: Paclitaxel, Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Condición: Brenner Tumor Fallopian Tube Cancer Procedure: adjuvant therapy Drug: paclitax Completed Nombre del estudio: A6 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Condición: Fallopian Tube Carcinoma Malignant Ovarian Mixed Epithelial Tumor Biological: Urokinase-Derived Peptide A6 Recruiting Nombre del estudio: MV-NIS Infected Mesenchymal Stem Cells in Treating Patients With Recurrent Ovarian Cancer Condición: Malignant Ovarian Brenner Tumor Ovarian Clear Cell Adenocarcino Fecha: 2014-02-19 Intervenciones: Other: Laboratory Biomarker Analysis Withdrawn Nombre del estudio: Acetyl-L-Carnitine Hydrochloride in Preventing Peripheral Neuropathy in Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy Condición: Fatigue Malignant Ovarian Mixed Epithelial Tumor Neuropath Fecha: 2011-12-14 Intervenciones: Dietary Supplement: Acetyl-L-Carnitine Hydrochloride Active, not recruiting Nombre del estudio: Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Condición: Fallopian Tube Clear Cell Adenocarcinoma Fallopian Tube Endometrioid Adenocarcinoma Fecha: 2009-04-24 Intervenciones: Drug: Elesclomol Sodium Given Recruiting Nombre del estudio: Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Condición: Clear Cell Adenocarcinoma Fallopian Tube Clear Cell Adenocarcinoma Biological: Bevacizumab Given Completed Nombre del estudio: Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer Condición: Chemotherapeutic Agent Toxicity Endometrial Adenocarcinoma Fecha: 2008-12-20 Intervenciones: Drug: Paclitaxel Given IV or i